To determine the accuracy of SCreening for Occult REnal Disease (SCORED) questionnaire for CKD risk among Asian Patients

Trial Identifier: D1843R00353
Sponsor: AstraZeneca
NCTID:: NCT05866276
Start Date: June 2023
Primary Completion Date: May 2024
Study Completion Date: May 2024
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Indonesia Surabaya, Indonesia
Indonesia, Jawa barat Bandung, Jawa barat, Indonesia, 40115
Vietnam Ho Chi Minh City, Vietnam, 70000